Novian Health Competitors and Similar CompaniesClear all

Novian Health's competitors and similar companies include Respicardia, Tactile Medical, AdaptHealth and Regentys Corporation.

	Novian Health Novian Health is a medical device company employing its proprietary interstitial laser therapy for the treatment of breast tumors.	Respicardia Respicardia develops implantable therapies to improve respiratory and cardiovascular health.	Tactile Medical Tactile Medical is advancing the standard of care in treating chronic diseases at home.	AdaptHealth AdaptHealth a full-service home medical equipment and respiratory company offering a breadth of clinically-focused products and services.	Regentys Corporation Regentys (formerly Asana Medical) is a medicine company developing treatments for patients with gastrointestinal (GI) disorders.
Founding Date	Founding Date 1991	Founding Date 2006	Founding Date 2006	Founding Date 2012	Founding Date 2013
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy	Tags Healthcare healthtech medical devices therapy
Locations	Locations Chicago, US HQ évry Courcouronnes, FR Chicago, US Tonganoxie, US	Locations Hopkins, US HQ	Locations Minneapolis, US HQ	Locations Conshohocken, US HQ Phoenixville, US	Locations Hialeah, US HQ
Employees	Employees 9	Employees 94	Employees 62926% increase	Employees 2,6011% increase	Employees 5
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 346.8 m	Valuation ($) 1.5 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $329.5m (FY, 2025)	Revenue (est.) $3.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $79.4m (FY, 2025)	Cost of goods $2.6b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $250.1m (FY, 2025)	Gross profit $609.2m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income $19.1m (FY, 2025)	Net income ($66m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 24.7m	Total funding raised $ 149.1m	Total funding raised $ 23.2m	Total funding raised N/A	Total funding raised $ 1.2m